TPG likely to beat earnings estimates according to Macquarie. My numbers tell the same. https://www.********.au/2018/01/16/...ocus-group-ltd-just-got-hit-with-a-downgrade/
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%